Concepedia

Julie Lekstrom-Himes

JL

36

Publications

5.9K

Citations

27

H-Index

1994

Active since

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Vertex Pharmaceuticals (United States)

National Human Genome Research Institute

Harvard University

Julie Lekstrom-Himes is an author at National Institutes of Health specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1994–2020

36

Publications

36

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone et al. · New England Journal of Medicine · 2017 · 765 citations · Full text

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

Steven M. Rowe, Cori Daines, Felix C. Ringshausen et al. · New England Journal of Medicine · 2017 · 499 citations · Full text

Enhancement of Hematopoietic Stem Cell Repopulating Capacity and Self-Renewal in the Absence of the Transcription Factor C/EBPα

Pu Zhang, Junko Iwasaki-Arai, Hiromi Iwasaki et al. · Immunity · 2004 · 497 citations · Full text

, , +8

Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ɛ-deficient mice

Ryuya Yamanaka, Carrolee Barlow, Julie Lekstrom-Himes et al. · Proceedings of the National Academy of Sciences · 1997 · 383 citations · Full text

, , +19

Rows per page

1–5 of 36